Screener
Ginkgo Bioworks DNA Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
| Net decrease in cash, cash equivalents and restricted cash | (40,356) | (354,392) |
| Cash and cash equivalents, beginning of period | 167,202 | 561,572 |
| Restricted cash, beginning of period | 45,169 | 44,171 |
| Cash, cash equivalents and restricted cash, beginning of period | 212,371 | 605,743 |
| Cash and cash equivalents, end of period | 84,535 | 203,566 |
| Restricted cash, end of period | 87,480 | 47,785 |
| Cash, cash equivalents and restricted cash, end of period | $172,015 | $251,351 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Ginkgo Bioworks's net change in cash?
- Ginkgo Bioworks (DNA) reported net change in cash of -$16.65M in Q2 2026.
- How has Ginkgo Bioworks's net change in cash changed year-over-year?
- Ginkgo Bioworks's net change in cash increased by 84.0% year-over-year, from -$104.05M to -$16.65M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Ginkgo Bioworks's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude